SCHEMBL19193024

SCHEMBL19193024

NC(O)c1ccc(-c2cc(F)ccc2Cc2nc3c(cnn3C3CCC(F)(F)CC3)c(=O)[nH]2)cn1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7934035 0.89 PDE9A (0.56) PDE9A
SCHEMBL6340015 0.87 PDE9A (0.54) PDE9A
SCHEMBL6339138 0.87 PDE9A (0.66) PDE9A
SCHEMBL6342877 0.86 PDE9A (0.56) PDE9A
SCHEMBL6341968 0.85 PDE9A (0.62) PDE9A
SCHEMBL6339235 0.85 PDE9A (0.64) PDE9A
SCHEMBL6339180 0.84 PDE9A (0.64) PDE9A
SCHEMBL7934026 0.83 PDE9A (0.61) PDE9A
SCHEMBL6339305 0.83 PDE9A (0.67) PDE9A
SCHEMBL6339629 0.82 PDE9A (0.55) PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334684-B1 PYRAZOLOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS BOEHRINGER INGELHEIM INT (DE) 2017-08-02 — — EP disclosed
Send feedback